JP2021077382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021077382A5 JP2021077382A5 JP2020219903A JP2020219903A JP2021077382A5 JP 2021077382 A5 JP2021077382 A5 JP 2021077382A5 JP 2020219903 A JP2020219903 A JP 2020219903A JP 2020219903 A JP2020219903 A JP 2020219903A JP 2021077382 A5 JP2021077382 A5 JP 2021077382A5
- Authority
- JP
- Japan
- Prior art keywords
- knowledge
- entry
- management system
- attribute description
- tree
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006870 function Effects 0.000 claims description 10
- 238000013515 script Methods 0.000 claims description 7
- 230000008676 import Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 2
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 201000001421 hyperglycemia Diseases 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 8
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 230000007170 pathology Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 239000004020 conductor Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 208000002682 Hyperkalemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000007345 glycogen storage disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000030133 remittent fever Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000027790 Rib fracture Diseases 0.000 description 1
- 101710195583 Urinary protein 2 Proteins 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019098163 | 2019-05-26 | ||
| JP2019098163 | 2019-05-26 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019207571A Division JP6928332B2 (ja) | 2019-05-26 | 2019-11-18 | 知識管理システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021077382A JP2021077382A (ja) | 2021-05-20 |
| JP2021077382A5 true JP2021077382A5 (enExample) | 2022-03-02 |
| JP7083977B2 JP7083977B2 (ja) | 2022-06-14 |
Family
ID=73546435
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019207571A Active JP6928332B2 (ja) | 2019-05-26 | 2019-11-18 | 知識管理システム |
| JP2020219903A Active JP7083977B2 (ja) | 2019-05-26 | 2020-12-30 | 知識管理システム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019207571A Active JP6928332B2 (ja) | 2019-05-26 | 2019-11-18 | 知識管理システム |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12400131B2 (enExample) |
| EP (1) | EP3979181A4 (enExample) |
| JP (2) | JP6928332B2 (enExample) |
| WO (1) | WO2020241534A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6913308B2 (ja) * | 2018-07-04 | 2021-08-04 | 株式会社医療情報技術研究所 | 医療文書管理システム |
| JP7284970B1 (ja) | 2022-09-09 | 2023-06-01 | 株式会社医療情報技術研究所 | 電子カルテ記録集約／参照システム |
| CN118277593B (zh) * | 2024-06-04 | 2024-08-06 | 青岛知识谷云科技有限公司 | 一种基于模块的知识管理方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5644686A (en) * | 1994-04-29 | 1997-07-01 | International Business Machines Corporation | Expert system and method employing hierarchical knowledge base, and interactive multimedia/hypermedia applications |
| JPH09179739A (ja) * | 1995-12-27 | 1997-07-11 | Canon Inc | 情報処理システム及びその方法 |
| GB2369460A (en) * | 2000-09-29 | 2002-05-29 | Reservoirteam Ltd | Knowledge based project management system |
| US6946715B2 (en) * | 2003-02-19 | 2005-09-20 | Micron Technology, Inc. | CMOS image sensor and method of fabrication |
| EP1625516A1 (en) | 2003-05-16 | 2006-02-15 | NTT DoCoMo, Inc. | Personalized service selection |
| JP2005084754A (ja) * | 2003-09-04 | 2005-03-31 | Hitachi Software Eng Co Ltd | 辞書引きリンクタグ付与システム |
| US7870117B1 (en) | 2006-06-01 | 2011-01-11 | Monster Worldwide, Inc. | Constructing a search query to execute a contextual personalized search of a knowledge base |
| JP4829381B2 (ja) * | 2009-05-18 | 2011-12-07 | 隆敏 柳瀬 | 知識ベースシステム、論理演算方法、プログラム、及び記録媒体 |
| US20110246501A1 (en) * | 2010-03-31 | 2011-10-06 | Accelrys Inc. | Systems and methods for entity registration and management |
| WO2015186205A1 (ja) * | 2014-06-04 | 2015-12-10 | 株式会社日立製作所 | 診療データ検索システム |
| JP5893791B1 (ja) * | 2015-07-28 | 2016-03-23 | 株式会社医療情報技術研究所 | 多施設統合文書管理システム |
| US10831811B2 (en) * | 2015-12-01 | 2020-11-10 | Oracle International Corporation | Resolution of ambiguous and implicit references using contextual information |
| US20170344886A1 (en) * | 2016-05-25 | 2017-11-30 | Tse-Kin Tong | Knowledge Management System also known as Computer Machinery for Knowledge Management |
| JP6814482B2 (ja) * | 2017-11-29 | 2021-01-20 | 株式会社医療情報技術研究所 | 知識管理システム |
-
2019
- 2019-11-18 JP JP2019207571A patent/JP6928332B2/ja active Active
-
2020
- 2020-05-24 WO PCT/JP2020/020433 patent/WO2020241534A1/ja not_active Ceased
- 2020-05-24 EP EP20813236.5A patent/EP3979181A4/en active Pending
- 2020-12-30 JP JP2020219903A patent/JP7083977B2/ja active Active
-
2021
- 2021-10-20 US US17/506,084 patent/US12400131B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leydesdorff et al. | Metaphors and diaphors in science communication: Mapping the case of stem cell research | |
| US11605005B2 (en) | Knowledge management system | |
| JP7083977B2 (ja) | 知識管理システム | |
| JP6913308B2 (ja) | 医療文書管理システム | |
| CN104769588B (zh) | 队列识别系统 | |
| Zhou et al. | Clinical decision support system for hypertension medication based on knowledge graph | |
| JP2021077382A5 (enExample) | ||
| Corwin et al. | Dynamic tables: an architecture for managing evolving, heterogeneous biomedical data in relational database management systems | |
| JP6868860B2 (ja) | 知識管理システム | |
| Bartalesi et al. | A web application for exploring primary sources: The DanteSources case study | |
| JP2020129385A5 (enExample) | ||
| Bajracharya et al. | Entity event knowledge graph for powerful health informatics | |
| Bayoudhi et al. | A survey on versioning approaches and tools | |
| D Pierce et al. | SemanticDB: a semantic Web infrastructure for clinical research and quality reporting | |
| JP7008939B2 (ja) | 医療文書管理システム | |
| Allanic et al. | Biomist: a platform for biomedical data lifecycle management of neuroimaging cohorts | |
| Eichler | Metadata management in the data lake architecture | |
| JP2021012738A5 (enExample) | ||
| CH712619B1 (de) | Verfahren für einen bio-molekularen Retrieval-Engine. | |
| Schuler et al. | An asset management approach to continuous integration of heterogeneous biomedical data | |
| Laender et al. | Ciênciabrasil-the brazilian portal of science and technology | |
| Nadkarni et al. | Database architectures for neuroscience applications | |
| Frendo | Disembodied information: Metadata, file plans, and the intellectual organisation of records | |
| Guo | Integrating DICOM Objects with a Database Management System | |
| Papež | Archetype-based approach for modelling of electroencephalographic/event-related potentials data and metadata |